Camp4 Therapeutics
(NASDAQ) CAMP
Camp4 Therapeutics Financials at a Glance
Market Cap
$237.79M
Revenue (TTM)
$3.50M
Net Income (TTM)
$80.40M
EPS (TTM)
$-2.57
P/E Ratio
-1.78
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$4.47
Volume
1,211
Open
$4.65
Price
$4.47
Volume
1,211
Open
$4.65
Previous Close
$4.47
Daily Range
$4.40 - $4.65
52-Week Range
$1.30 - $7.75
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$4.47
Volume
1,211
Open
$4.65
Previous Close
$4.47
Daily Range
$4.40 - $4.65
52-Week Range
$1.30 - $7.75
CAMP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Camp4 Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
48
CEO
Josh Mandel-Brehm, MBA
Website
www.camp4tx.comHeadquarters
Cambridge, MA 02139, US
CAMP Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
-15%
Net Income Margin
-23%
Return on Equity
-145%
Return on Capital
-51%
Return on Assets
-68%
Earnings Yield
-56.18%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$237.79M
Shares Outstanding
51.92M
Volume
1.21K
Short Interest
0.00%
Avg. Volume
192.08K
Financials (TTM)
Gross Profit
$1.86M
Operating Income
$52.06M
EBITDA
$50.42M
Operating Cash Flow
$29.55M
Capital Expenditure
$279.00K
Free Cash Flow
$29.83M
Cash & ST Invst.
$109.52M
Total Debt
$1.97M
Camp4 Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$348.00K
-46.6%
Gross Profit
$24.00K
-103.7%
Gross Margin
-6.90%
N/A
Market Cap
$237.79M
N/A
Market Cap/Employee
$4.32M
N/A
Employees
55
N/A
Net Income
$40.28M
-203.4%
EBITDA
$12.40M
+8.9%
Quarterly Fundamentals
Net Cash
$107.54M
+94.2%
Accounts Receivable
$155.00K
+43.5%
Inventory
$0.00
N/A
Long Term Debt
$1.69M
-69.7%
Short Term Debt
$286.00K
-90.7%
Return on Assets
-68.25%
N/A
Return on Invested Capital
-50.89%
N/A
Free Cash Flow
$6.29M
+154.5%
Operating Cash Flow
$6.29M
+155.7%